Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Steven E Schild

Department of Radiation Oncology, Mayo Clinic Arizona, Scottsdale 85259, USA

Biography

The research of Steven E. Schild, M.D., is focused mainly on the treatment of tumors arising in the lung and prostate gland. This includes writing experimental trials involving new cancer treatments, His work has been performed primarily at Mayo Clinic and the Alliance for Clinical Trials in Oncology, which was formed when the North Central Cancer Treatment Group (NCCTG) merged with two other groups. Department of Radiation Oncology, Mayo Clinic Arizona, Scottsdale 85259, USA
Publications

Patient Specific Characteristics Are an Important Factor That Determines the Risk of Acute Grade ≥ 2 Rectal Toxicity in Patients Treated for Prostate Cancer with IMRT and Daily Image Guidance Based on Implanted Gold Markers

Aim: To model acute rectal toxicity in Intensity Modulated Radiation Therapy (IMRT) for prostate cancer using dosimetry and patient specific characteristics. Methods: A database of 79 prostate cancer patients treated with image guided IMRT was used to fit parameters of Lyman-Kutcher-Burman (LKB) and logistic regression Normal Tissue Complications ... Read More»

Xiaonan Liu, Jing Li, Teresa Wu, Steven E Schild, Michael H Schild, William Wong, Sujay Vora and Mirek Fatyga

Research Article: OMICS J Radiol 2016, 5: 225

DOI: 10.4172/2167-7964.1000225

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

Top